Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
MS as a gateway disease.
Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections.
Abnormal brain iron metabolism in irp2 deficient mice is associated with mild neurological and behavioral impairments.
Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association?
Functional connectivity analyses using emulated and conventional resting state data: Parts vs. the whole story.
Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
Response to Letter to the Editor 'Simvastatin improves final visual outcome in acute optic neuritis, a randomized study'
Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.
Is It Too Early to Predict the Failure of Natalizumab in NMO?
Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis.
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Temporal aspects of visual perception in demyelinative diseases.
Highlights from the 31st ECTRIMS congress - Barcelona 2015.
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis.
Inadvertent foley catheterization of the ureter.
Retinal thickness in pediatric multiple sclerosis.
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010.
The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
Prevalence and Impact of Pain in Adults Aging With a Physical Disability: Comparison to a US General Population Sample.
The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.
KATP Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation.
Virtual rehabilitation for multiple sclerosis using a kinect-based system: randomized controlled trial.
Pages
« first
‹ previous
…
324
325
326
327
328
329
330
331
332
…
next ›
last »